Evaluation of safety in the ethical use of erwininia L-asparaginase (erwinase) for patients with acute lymphoblastic leukemia and lymphoblastic lymphoma

Trial Profile

Evaluation of safety in the ethical use of erwininia L-asparaginase (erwinase) for patients with acute lymphoblastic leukemia and lymphoblastic lymphoma

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 07 May 2012

At a glance

  • Drugs Crisantaspase (Primary)
  • Indications Precursor cell lymphoblastic leukaemia-lymphoma
  • Focus Adverse reactions
  • Most Recent Events

    • 07 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top